BioCardia Announces European Patent Office Decision to Grant Patent on Autologous Cell Therapy Patient Selection Diagnostic Assay
21 juin 2021 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
BioCardia to Be Added to the Russell Microcap® Index
14 juin 2021 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies,...
BioCardia to Present at the LD Micro Virtual Invitational Conference on June 8, 2021
02 juin 2021 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., June 02, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies,...
BioCardia Reports First Quarter 2021 Financial Results and Business Highlights
13 mai 2021 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular and pulmonary cell based therapies,...
BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates
26 avr. 2021 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], today announced that it has entered into an agreement with a leading Japanese biotechnology company related to...
BioCardia Reports 2020 Financial Results and Recent Business Highlights
30 mars 2021 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular and pulmonary regenerative...
BioCardia to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference
15 mars 2021 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, announces...
BioCardia Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates
23 févr. 2021 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], today announced that it has entered into an agreement with a leading Japanese pharmaceutical company related to...
BioCardia Announces Clinical Leadership Changes
17 févr. 2021 08h30 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioCardia Update on Cell Therapy Product Development and 2021 Milestones
02 févr. 2021 08h30 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today provides...